ClinicalTrials.Veeva

Menu

Use of Sentinel Cells for the Development of Molecular Tests to Control the Quality of Cryopreservation

U

University Hospital Center (CHU) Dijon Bourgogne

Status

Withdrawn

Conditions

Aneurysm of the Abdominal Aorta

Study type

Observational

Funder types

Other

Identifiers

NCT01904825
Bonnin PHRC IR 2006

Details and patient eligibility

About

The aim is to set up tools that will serve as quality tracers for cryopreservation procedures.

To meet this objective, we have chosen to develop reference samples (sentinel cells) that, in the medium term, can be used as controls to guarantee the quality of preservation for biological samples.

The biological tools and an optimised follow-up strategy will make it possible to validate preservation procedures at the CRB in order to guarantee the perfect stability of samples and the validity of clinical studies.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age > or = 18 years
  • All patients presenting an abdominal aorta diameter of at least 5 cm at the time of discovery and who have surgery

Exclusion criteria

  • Patients who do not have aneurysm of the abdominal aorta
  • Refusal to sign the consent form for participation
  • Patients who do not wish to have their operation in Dijon or Strasbourg CHU

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems